United States - English - NLM (National Library of Medicine)

akorn - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - ketorolac tromethamine ophthalmic solution is indicated for the treatment of pain and inflammation following cataract surgery. ketorolac tromethamine ophthalmic solution is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation. teratogenic effects. pregnancy category c: ketorolac tromethamine, administered during organogenesis, was not teratogenic in rabbits and rats at oral doses of 3.6 mg/kg/day and 10 mg/kg/day, respectively. these doses are approximately 600 times and 1,700 times higher respectively than the typical human topical ophthalmic daily dose of 0.35 mg (4.5 mg/ml x 0.04 ml/drop, twice daily) to an affected eye on a mg/kg basis. additionally, when administered to rats after day 17 of gestation at oral doses up to 1.5 mg/kg/day (approximately 300 times the typical human topical ophthalmic daily dose), ketorolac tromethamine resulted in dystocia and increased pup mortality. there are no adequate and well-controlled studies in pregnan

Ireland - English - HPRA (Health Products Regulatory Authority)

mercurypharm ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibacterials for systemic use - pigs; cattle; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis sensitive to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica sensitive to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. draxxin should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - selamectin - antiparasitic products, insecticides and repellents, endectocides, macrocyclic lactones, - dogs; cats - cats and dogs: treatment and prevention of flea infestations caused by ctenocephalides spp. for one month following a single administration. this is as a result of the adulticidal, larvicidal and ovicidal properties of the product. the product is ovicidal for 3 weeks after administration. through a reduction in the flea population, monthly treatment of pregnant and lactating animals will also aid in the prevention of flea infestations in the litter up to seven weeks of age. the product can be used as part of a treatment strategy for flea allergy dermatitis and through its ovicidal and larvicidal action may aid in the control of existing environmental flea infestations in areas to which the animal has access.prevention of heartworm disease caused by dirofilaria immitis with monthly administration. stronghold may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with stronghold. it is also recommended that dogs should be tested periodically for adult heartworm infections, as an integral part of a heartworm prevention strategy, even when stronghold has been administered monthly. this product is not effective against adult d. immitis.treatment of ear mites (otodectes cynotis). cats:treatment of biting lice infestations (felicola subrostratustreatment of adult roundworms (toxocara cati)treatment of adult intestinal hookworms (ancylostoma tubaeforme). dogs:treatment of biting lice infestations (trichodectes canis)treatment of sarcoptic mange (caused by sarcoptes scabiei)treatment of adult intestinal roundworms (toxocara canis).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin international uk newco ltd - propantheline bromide - oral tablet - 15mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - glycopyrronium bromide - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - glycopyrronium bromide - solution for injection - 200microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - glycopyrronium bromide - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - glycopyrronium bromide - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - glycopyrronium bromide - solution for injection - 200microgram/1ml